Analyst Ratings For NASDAQ:AGIO – Agios Pharmaceuticals (NASDAQ:AGIO)
Today, Citigroup initiated coverage on NASDAQ:AGIO – Agios Pharmaceuticals (NASDAQ:AGIO) with a Buy.
Some recent analyst ratings include
- 5/23/2018-Citigroup initiated coverage with a Buy rating.
- 4/17/2018-Cann Reiterated Rating of Hold.
- 2/14/2018-Oppenheimer was Downgraded by analysts at Oppenheimer from a “Outperform ➝ Market Perform” rating to a “” rating.
Recent Insider Trading Activity For NASDAQ:AGIO – Agios Pharmaceuticals (NASDAQ:AGIO)
NASDAQ:AGIO – Agios Pharmaceuticals (NASDAQ:AGIO) has insider ownership of 3.02% and institutional ownership of 93.99%.
- On 5/7/2018 Scott Biller, Insider, sold 3,000 with an average share price of $81.81 per share and the total transaction amounting to $245,430.00.
- On 5/1/2018 David P Schenkein, CEO, sold 13,000 with an average share price of $83.04 per share and the total transaction amounting to $1,079,520.00.
- On 4/23/2018 Steven L Hoerter, Insider, sold 2,050 with an average share price of $85.95 per share and the total transaction amounting to $176,197.50.
- On 4/12/2018 Christopher Bowden, Insider, sold 2,000 with an average share price of $85.10 per share and the total transaction amounting to $170,200.00.
- On 4/5/2018 Scott Biller, Insider, sold 3,000 with an average share price of $75.20 per share and the total transaction amounting to $225,600.00.
- On 4/2/2018 David P Schenkein, CEO, sold 13,000 with an average share price of $77.72 per share and the total transaction amounting to $1,010,360.00.
- On 3/22/2018 Steven L Hoerter, Insider, sold 2,050 with an average share price of $84.65 per share and the total transaction amounting to $173,532.50.
Recent Trading Activity for NASDAQ:AGIO – Agios Pharmaceuticals (NASDAQ:AGIO)
Shares of NASDAQ:AGIO – Agios Pharmaceuticals closed the previous trading session at 89.56 up +3.62 4.21% with 90.22000122070312 shares trading hands.
